Literature DB >> 12777390

Localization of the deoxyribose phosphate lyase active site in human DNA polymerase iota by controlled proteolysis.

Rajendra Prasad1, Katarzyna Bebenek, Esther Hou, David D Shock, William A Beard, Roger Woodgate, Thomas A Kunkel, Samuel H Wilson.   

Abstract

Human DNA polymerase iota (pol iota) is a member of the Y-family of low fidelity lesion bypass DNA polymerases. In addition to a probable role in DNA lesion bypass, this enzyme has recently been shown to be required for somatic hypermutation in human B-cells. We found earlier that human pol iota has deoxyribose phosphate (dRP) lyase activity and unusual specificity for activity during DNA synthesis, suggesting involvement in specialized forms of base excision repair (BER). Here, mapping of the domain structure of human pol iota by controlled proteolysis revealed that the enzyme has a 48-kDa NH2-terminal domain and a protease resistant 40-kDa "core domain" spanning residues Met79 to approximately Met445. A covalently cross-linked pol iota-DNA complex, representing a trapped intermediate in the dRP lyase reaction, was subjected to controlled proteolysis. Cross-linking was mapped to the 40-kDa core domain, indicating that the dRP lyase active site is in this region. To further evaluate the BER capacity of the enzyme, the dRP lyase and DNA polymerase activities were characterized on DNA substrates representing BER intermediates, and we found that pol iota was able to complement the in vitro single-nucleotide BER deficiency of a DNA polymerase beta null cell extract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777390     DOI: 10.1074/jbc.M305399200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  A mechanism for the exclusion of low-fidelity human Y-family DNA polymerases from base excision repair.

Authors:  Lajos Haracska; Louise Prakash; Satya Prakash
Journal:  Genes Dev       Date:  2003-11-15       Impact factor: 11.361

Review 2.  Targeting DNA polymerase ß for therapeutic intervention.

Authors:  Eva M Goellner; David Svilar; Karen H Almeida; Robert W Sobol
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

3.  DNA polymerase beta null mouse embryonic fibroblasts harbor a homozygous null mutation in DNA polymerase iota.

Authors:  Robert W Sobol
Journal:  DNA Repair (Amst)       Date:  2006-09-18

Review 4.  The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases.

Authors:  Scott D McCulloch; Thomas A Kunkel
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

Review 5.  Y-family DNA polymerases in mammalian cells.

Authors:  Caixia Guo; J Nicole Kosarek-Stancel; Tie-Shan Tang; Errol C Friedberg
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

Review 6.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks.

Authors:  Michael D Wyatt; Douglas L Pittman
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

Review 7.  Translesion DNA polymerases in eukaryotes: what makes them tick?

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-03-09       Impact factor: 8.250

Review 8.  Regulation of translesion DNA synthesis: Posttranslational modification of lysine residues in key proteins.

Authors:  Justyna McIntyre; Roger Woodgate
Journal:  DNA Repair (Amst)       Date:  2015-02-18

Review 9.  Mysterious and fascinating: DNA polymerase ɩ remains enigmatic 20 years after its discovery.

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  DNA Repair (Amst)       Date:  2020-09

10.  A real-time fluorescence method for enzymatic characterization of specialized human DNA polymerases.

Authors:  Dorjbal Dorjsuren; David M Wilson; William A Beard; John P McDonald; Christopher P Austin; Roger Woodgate; Samuel H Wilson; Anton Simeonov
Journal:  Nucleic Acids Res       Date:  2009-08-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.